Kim Barbara Luley

4.7k total citations
34 papers, 659 citations indexed

About

Kim Barbara Luley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Kim Barbara Luley has authored 34 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 14 papers in Gastroenterology. Recurrent topics in Kim Barbara Luley's work include Gastric Cancer Management and Outcomes (22 papers), Gastrointestinal Tumor Research and Treatment (14 papers) and Esophageal Cancer Research and Treatment (10 papers). Kim Barbara Luley is often cited by papers focused on Gastric Cancer Management and Outcomes (22 papers), Gastrointestinal Tumor Research and Treatment (14 papers) and Esophageal Cancer Research and Treatment (10 papers). Kim Barbara Luley collaborates with scholars based in Germany, Austria and Canada. Kim Barbara Luley's co-authors include Nils Homann, Claudia Pauligk, Salah‐Eddin Al‐Batran, Peter Thuss‐Patience, Stephan Probst, Ralf‐Dieter Hofheinz, Nicole Prasnikar, Elke Jäger, Thorsten Oliver Goetze and F. Noack and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Kim Barbara Luley

32 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim Barbara Luley Germany	12	494	363	236	184	87	34	659
Young‐Jae Mok South Korea	16	489 1.0×	325 0.9×	140 0.6×	347 1.9×	38 0.4×	31	663
Kwang Yeol Paik South Korea	13	341 0.7×	446 1.2×	402 1.7×	50 0.3×	75 0.9×	50	620
Osamu Hosokawa Japan	13	618 1.3×	571 1.6×	394 1.7×	164 0.9×	94 1.1×	26	819
António Gouveia Portugal	12	177 0.4×	261 0.7×	148 0.6×	141 0.8×	34 0.4×	26	445
Jong-Han Kim South Korea	17	445 0.9×	312 0.9×	114 0.5×	284 1.5×	42 0.5×	31	629
Sung Tae Oh South Korea	18	659 1.3×	381 1.0×	206 0.9×	368 2.0×	78 0.9×	54	800
Cian Muldoon Ireland	9	241 0.5×	254 0.7×	133 0.6×	37 0.2×	53 0.6×	17	372
Daisuke Takayanagi Japan	11	143 0.3×	119 0.3×	245 1.0×	49 0.3×	69 0.8×	35	384
Seong-Heum Park South Korea	13	329 0.7×	214 0.6×	89 0.4×	218 1.2×	28 0.3×	21	456
André L. Montagnini Brazil	11	217 0.4×	284 0.8×	268 1.1×	59 0.3×	54 0.6×	16	445

Countries citing papers authored by Kim Barbara Luley

Since Specialization

Citations

This map shows the geographic impact of Kim Barbara Luley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Barbara Luley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Barbara Luley more than expected).

Fields of papers citing papers by Kim Barbara Luley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Barbara Luley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Barbara Luley. The network helps show where Kim Barbara Luley may publish in the future.

Co-authorship network of co-authors of Kim Barbara Luley

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Barbara Luley. A scholar is included among the top collaborators of Kim Barbara Luley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Barbara Luley. Kim Barbara Luley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Batran, Salah‐Eddin, Thorsten Oliver Goetze, Peter Thuss‐Patience, et al.. (2024). Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy. International Journal of Cancer. 154(12). 2142–2150. 5 indexed citations

Hirsch, Daniela, Wilko Weichert, Thorsten Oliver Götze, et al.. (2023). Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. European Journal of Cancer. 183. 119–130. 1 indexed citations

Ungefroren, Hendrik, Axel Künstner, Hauke Busch, et al.. (2022). Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling. International Journal of Molecular Sciences. 23(24). 15868–15868. 7 indexed citations

Lorenzen, Sylvie, Peter Thuss‐Patience, Jorge Riera Knorrenschild, et al.. (2022). 1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO. Annals of Oncology. 33. S1099–S1099. 2 indexed citations

Lindner, Kirsten, Jens Hoeppner, Ulrich F. Wellner, et al.. (2021). Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms—A Single-Center Retrospective Outcome Analysis. Current Oncology. 28(4). 3071–3080. 5 indexed citations

Czauderna, Carolin, Kim Barbara Luley, Nikolas von Bubnoff, & Jens U. Marquardt. (2021). Tailored Systemic Therapy for Colorectal Cancer Liver Metastases. International Journal of Molecular Sciences. 22(21). 11780–11780. 11 indexed citations

Luley, Kim Barbara, Axel Künstner, Hauke Busch, et al.. (2020). A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1. Cancers. 12(3). 691–691. 34 indexed citations

Pauligk, Claudia, Peter Thuss‐Patience, Jorge Riera‐Knorrenschild, et al.. (2020). 1443P Modified FOLFOX versus modified FOLFOX plus nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – Safety Results from AIO-STO-0417: A randomized phase II trial of the German Gastric Group of the AIO. Annals of Oncology. 31. S908–S908. 6 indexed citations

Luley, Kim Barbara, Judith Gebauer, Niklas Gebauer, et al.. (2020). Gastroenteropankreatische neuroendokrine Neoplasien – Heterogenität, Management und Perspektiven der Versorgung und Forschung. Der Internist. 61(8). 875–890. 4 indexed citations

10.

Kacprowski, Tim, Tobias Keck, Franck Billmann, et al.. (2018). MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases. Oncotarget. 9(47). 28379–28390. 28 indexed citations

11.

Al‐Batran, Salah‐Eddin, Nils Homann, Harald Schmalenberg, et al.. (2017). Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.. Journal of Clinical Oncology. 35(15_suppl). 4004–4004. 164 indexed citations

12.

Pauligk, Claudia, Sylvie Lorenzen, Thorsten Oliver Goetze, et al.. (2017). A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC). Annals of Oncology. 28. v228–v228. 2 indexed citations

13.

Lorenzen, Sylvie, Jorge Riera Knorrenschild, Claudia Pauligk, et al.. (2017). A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).. Journal of Clinical Oncology. 35(15_suppl). 4027–4027. 5 indexed citations

14.

Pauligk, Claudia, Andrea Tannapfel, Jens Meiler, et al.. (2015). 36LBA Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO. European Journal of Cancer. 51. S728–S728. 2 indexed citations

15.

Al‐Batran, Salah‐Eddin, Ralf‐Dieter Hofheinz, Nils Homann, et al.. (2012). A prospective trial for defining a subset of patients with limited metastatic gastric cancer who may be candidates for bimodal treatment strategies: FLOT3.. Journal of Clinical Oncology. 30(15_suppl). 4090–4090. 5 indexed citations

16.

Al‐Batran, Salah‐Eddin, Claudia Pauligk, Nils Homann, et al.. (2012). The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+). European Journal of Cancer. 49(4). 835–842. 102 indexed citations

17.

Al-Batran, S., Ralf‐Dieter Hofheinz, Nils Homann, et al.. (2011). Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).. Journal of Clinical Oncology. 29(15_suppl). 4070–4070. 4 indexed citations

18.

Homann, Nils, Claudia Pauligk, Kim Barbara Luley, et al.. (2011). Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5‐fluorouracil, oxaliplatin and docetaxel. International Journal of Cancer. 130(7). 1706–1713. 75 indexed citations

19.

Luley, Kim Barbara, F. Noack, Hendrik Lehnert, & Nils Homann. (2011). Local calprotectin production in colorectal cancer and polyps—active neutrophil recruitment in carcinogenesis. International Journal of Colorectal Disease. 26(5). 603–607. 17 indexed citations

20.

Luley, Kim Barbara & Thomas Wagner. (2009). Idiopathische thrombozytopenische Purpura (Morbus Werlhof) und ihre Abgrenzung von anderen thrombozytopenischen hämorrhagischen Diathesen. Medizinische Klinik. 104(5). 372–383. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact